GR3024483T3 - Indano pyrrolidine carbamates - Google Patents

Indano pyrrolidine carbamates

Info

Publication number
GR3024483T3
GR3024483T3 GR970402122T GR970402122T GR3024483T3 GR 3024483 T3 GR3024483 T3 GR 3024483T3 GR 970402122 T GR970402122 T GR 970402122T GR 970402122 T GR970402122 T GR 970402122T GR 3024483 T3 GR3024483 T3 GR 3024483T3
Authority
GR
Greece
Prior art keywords
indano
carbamates
pyrrolidine
compounds
formula
Prior art date
Application number
GR970402122T
Other languages
English (en)
Inventor
Yuhpyng L Chen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR3024483T3 publication Critical patent/GR3024483T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Pyrane Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GR970402122T 1990-07-12 1997-08-19 Indano pyrrolidine carbamates GR3024483T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55197090A 1990-07-12 1990-07-12
PCT/US1991/004320 WO1992000961A1 (en) 1990-07-12 1991-06-25 Indano pyrrolidine carbamates

Publications (1)

Publication Number Publication Date
GR3024483T3 true GR3024483T3 (en) 1997-11-28

Family

ID=24203423

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402122T GR3024483T3 (en) 1990-07-12 1997-08-19 Indano pyrrolidine carbamates

Country Status (12)

Country Link
EP (1) EP0538314B1 (el)
JP (1) JPH0720933B2 (el)
AT (1) ATE154598T1 (el)
CA (1) CA2086433C (el)
DE (1) DE69126612T2 (el)
DK (1) DK0538314T3 (el)
ES (1) ES2103816T3 (el)
FI (2) FI104716B (el)
GR (1) GR3024483T3 (el)
IE (1) IE912423A1 (el)
PT (1) PT98268B (el)
WO (1) WO1992000961A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574060A (en) * 1993-08-12 1996-11-12 The United States Of America As Represented By The Department Of Health And Human Services Selective inhibitors of biogenic amine transporters
US5834487A (en) * 1996-09-24 1998-11-10 Cv Therapeutics Inhibition of 26S and 20S proteasome by indanones
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
US10865465B2 (en) 2017-07-27 2020-12-15 Terves, Llc Degradable metal matrix composite
GB2537576A (en) 2014-02-21 2016-10-19 Terves Inc Manufacture of controlled rate dissolving materials
US10150713B2 (en) 2014-02-21 2018-12-11 Terves, Inc. Fluid activated disintegrating metal system
US10689740B2 (en) 2014-04-18 2020-06-23 Terves, LLCq Galvanically-active in situ formed particles for controlled rate dissolving tools

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1304175A (el) * 1969-03-31 1973-01-24
GB1351754A (en) * 1970-07-02 1974-05-01 Allen & Hanburys Ltd Indenopyrrole derivatives
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use

Also Published As

Publication number Publication date
WO1992000961A1 (en) 1992-01-23
FI20000051A (fi) 2000-01-11
FI930092A0 (fi) 1993-01-11
DK0538314T3 (da) 1997-10-13
ATE154598T1 (de) 1997-07-15
CA2086433C (en) 2000-01-25
IE912423A1 (en) 1992-01-15
DE69126612T2 (de) 1997-10-02
PT98268A (pt) 1992-05-29
EP0538314B1 (en) 1997-06-18
ES2103816T3 (es) 1997-10-01
FI930092A (fi) 1993-01-11
FI104716B (fi) 2000-03-31
JPH05503293A (ja) 1993-06-03
DE69126612D1 (de) 1997-07-24
EP0538314A1 (en) 1993-04-28
JPH0720933B2 (ja) 1995-03-08
PT98268B (pt) 1998-12-31

Similar Documents

Publication Publication Date Title
ZA919629B (en) Novel 4-arylpiperazines and 4-arylpiperidines
PL250093A2 (en) Fungicide
GR3020451T3 (en) Retroviral protease inhibitors
CY2543B1 (en) 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
HU9301446D0 (en) Inhibitors or fetrovirus protease
FI925415A (fi) Framstaellning av substituerade piperidiner
GR3024483T3 (en) Indano pyrrolidine carbamates
AP9400632A0 (en) Ether derivatives.
GR3005254T3 (el)
GR1002598B (el) Παραγωγα επι-επιβατιδινης.
DE58901409D1 (en) Hydroxypropafenonglyceride.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
GR3018765T3 (en) Process for the preparation of N-(2-hydroxyethyl)-2-hydroxymethyl-3,4,5-trihydroxy-piperidine and of intermediates.
HU9402119D0 (en) Alkyl derivatives of trazodone
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
ES8708132A1 (es) Procedimiento para preparar n-fenil-4-fenil-1-piperazincarboxamidinas y compuestos afines como agentes anti-arritmicos
ATE108449T1 (de) Hydrochinondiether, ihre herstellung und ihre verwendung.
NZ234924A (en) 1,3-oxazine derivatives and antitussive compositions
IT1270054B (it) Composti ad attivita' ipocolesterolemica
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.
IT1266584B1 (it) Composti eterociclici ad attivita' cardiovascolare
GB2318353A (en) Metalloproteinase inhibitors
AU2057392A (en) Polyglucosides obtained from hydroxyalkylsorbitol
IT1255094B (it) Derivati tetraidropiridoimidazolonici come agenti nootropici